Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07336966

Does Recessive Optic Atrophy Due to WFS1 Exist?

Does Recessive Optic Atrophy Due to WFS1 is a Specific Entity Different From Wolfram Syndrome?

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
Hôpital Necker-Enfants Malades · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

All patients with Wolfram syndrome and recessive optic atrophy due to a mutation of the WFS1 from a single Center were included in a retrospective study. Evolution of the visual acuity since the occurrence of the optic atrophy and its last value, OCT data, genetic data and systemic manifestations were analyzed.

Detailed description

Ophthalmological date will be include : farsighted best corrected visual acuity (BCVA) assessment, slit-lamp examination of the anterior segment, Goldman aplanation tonometry, funduscopy, retinography, Goldman manual visual field and optical coherent tomography (OCT). These will include global value of Retinal Nerve Fiber Layer (RNFL) thickness as well as the ganglion cell complex (GCC) thickness.

Conditions

Interventions

TypeNameDescription
OTHERanalyse studyRetrospective analyse and study of recorded data of patients with wolfram syndrome or recessive optic atrophy due to WFS1 mutation

Timeline

Start date
2026-02-01
Primary completion
2026-03-01
Completion
2026-04-01
First posted
2026-01-13
Last updated
2026-01-13

Source: ClinicalTrials.gov record NCT07336966. Inclusion in this directory is not an endorsement.